SNP marker information for KIF1B gene for all subjects studied (patients and healthy controls).

<p>Chr. No.: Chromosome Number; SNPs: Single Nucleotide Polymorphisms; Position: Chromosomal Position; ObsHET: Observed Heterozygosity; PredHET: Predicted Heterozygosity; HWpval: Hardy-Weinberg P-value; MAF: Minor Allele Frequency.</p

Haplotypes of KIF1B gene variants when Cases III+IV groups were compared to case II (active group).

<p>Haplotypes of KIF1B gene variants when Cases III+IV groups were compared to case II (active group).</p

Genotypic distribution for KIF1B gene polymorphisms when cases III+IV groups were compared to case II (active group).

<p>Risk allele marked in <b>BOLD</b> letter.</p

Genotypic distribution for KIF1B gene polymorphisms when cases II+III+IV were compared to case I (inactive group).

<p>Risk allele marked in <b>BOLD</b> letter.</p

Haplotypes of KIF1B gene variants when patient (Cases I+II+III+IV) group was compared to control group.

<p>♦This value is insignificant when Bonefforoni correction was applied.</p

Genotypic distribution for KIF1B gene polymorphisms when patient (Cases I+II+III+IV) group was compared to control group.

<p>Risk allele marked in <b>BOLD</b> letter.</p

Genotypic distribution for HLA gene polymorphisms when patients (Groups I+II+III+IV) were compared to control group.

<p>Risk alleles marked in <b>BOLD</b> letters.</p

Pair-wise linkage disequilibrium analysis of five HLA SNPs.

<p>Pair-wise linkage disequilibrium analysis of five HLA SNPs.</p

Haplotype analysis for HLA gene polymorphisms between patients (Group I+II+III+IV) and controls.

<p>Haplotype analysis for HLA gene polymorphisms between patients (Group I+II+III+IV) and controls.</p

Baseline characteristics of all subjects included in this study.

<p>NA, Not available; BMI, body-mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase.</p>*<p>Values are expressed as median (interquartile ranges),</p>§<p>Mean ± SD.</p